537 related articles for article (PubMed ID: 37641132)
1. Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts.
Khan NA; Asim M; Biswas KH; Alansari AN; Saman H; Sarwar MZ; Osmonaliev K; Uddin S
J Exp Clin Cancer Res; 2023 Aug; 42(1):221. PubMed ID: 37641132
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived exosomes: immune properties and clinical application in lung cancer.
Wu J; Li S; Zhang P
Cancer Drug Resist; 2022; 5(1):102-113. PubMed ID: 35582534
[TBL] [Abstract][Full Text] [Related]
3. Development and Clinical Application of Tumor-derived Exosomes in Patients with Cancer.
Verdi J; Ketabchi N; Noorbakhsh N; Saleh M; Ebrahimi-Barough S; Seyhoun I; Kavianpour M
Curr Stem Cell Res Ther; 2022; 17(1):91-102. PubMed ID: 34161212
[TBL] [Abstract][Full Text] [Related]
4. Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation.
Castillo-Peña A; Molina-Pinelo S
Front Immunol; 2023; 14():1279495. PubMed ID: 37915578
[TBL] [Abstract][Full Text] [Related]
5. Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response.
Wu J; Zeng D; Zhi S; Ye Z; Qiu W; Huang N; Sun L; Wang C; Wu Z; Bin J; Liao Y; Shi M; Liao W
J Transl Med; 2021 Sep; 19(1):381. PubMed ID: 34496872
[TBL] [Abstract][Full Text] [Related]
6. Formation, contents, functions of exosomes and their potential in lung cancer diagnostics and therapeutics.
Xia Z; Qing B; Wang W; Gu L; Chen H; Yuan Y
Thorac Cancer; 2021 Dec; 12(23):3088-3100. PubMed ID: 34734680
[TBL] [Abstract][Full Text] [Related]
7. Theranostic signature of tumor-derived exosomes in cancer.
Kumar S; Dhar R; Kumar LBSS; Shivji GG; Jayaraj R; Devi A
Med Oncol; 2023 Oct; 40(11):321. PubMed ID: 37798480
[TBL] [Abstract][Full Text] [Related]
8. The Potential Biomarkers and Immunological Effects of Tumor-Derived Exosomes in Lung Cancer.
Alipoor SD; Mortaz E; Varahram M; Movassaghi M; Kraneveld AD; Garssen J; Adcock IM
Front Immunol; 2018; 9():819. PubMed ID: 29720982
[TBL] [Abstract][Full Text] [Related]
9. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
Alfonsi R; Grassi L; Signore M; Bonci D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798
[TBL] [Abstract][Full Text] [Related]
10. Exosomes in Cancer: Circulating Immune-Related Biomarkers.
Głuszko A; Szczepański MJ; Ludwig N; Mirza SM; Olejarz W
Biomed Res Int; 2019; 2019():1628029. PubMed ID: 31915681
[TBL] [Abstract][Full Text] [Related]
11. Role of Exosomes in Epithelial-Mesenchymal Transition.
Bhattacharya B; Nag S; Mukherjee S; Kulkarni M; Chandane P; Mandal D; Mukerjee N; Mirgh D; Anand K; Adhikari MD; Gorai S; Thorat N
ACS Appl Bio Mater; 2024 Jan; 7(1):44-58. PubMed ID: 38108852
[TBL] [Abstract][Full Text] [Related]
12. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
Sundararajan V; Sarkar FH; Ramasamy TS
Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
[TBL] [Abstract][Full Text] [Related]
13. Clinical Impact of Exosomes in Colorectal Cancer Metastasis.
Ghosh S; Dhar R; Gurudas Shivji G; Dey D; Devi A; Jha SK; Adhikari MD; Gorai S
ACS Appl Bio Mater; 2023 Jul; 6(7):2576-2590. PubMed ID: 37314223
[TBL] [Abstract][Full Text] [Related]
14. The biological functions and clinical applications of exosomes in lung cancer.
Chen R; Xu X; Qian Z; Zhang C; Niu Y; Wang Z; Sun J; Zhang X; Yu Y
Cell Mol Life Sci; 2019 Dec; 76(23):4613-4633. PubMed ID: 31352532
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived exosomes in the PD-1/PD-L1 axis: Significant regulators as well as promising clinical targets.
Liang B; Hu X; Ding Y; Liu M
J Cell Physiol; 2021 Jun; 236(6):4138-4151. PubMed ID: 33275291
[TBL] [Abstract][Full Text] [Related]
16. Exosomes carrying immune checkpoints, a promising therapeutic approach in cancer treatment.
Rasihashemi SZ; Sahrai H; Rezazadeh-Gavgani E; Yazdani Y; Khalaji A; Lotfinejad P
Med Oncol; 2022 Sep; 39(12):183. PubMed ID: 36071295
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived exosomes: Nanovesicles made by cancer cells to promote cancer metastasis.
Chen H; Chengalvala V; Hu H; Sun D
Acta Pharm Sin B; 2021 Aug; 11(8):2136-2149. PubMed ID: 34522581
[TBL] [Abstract][Full Text] [Related]
18. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo.
Chen Z; You L; Wang L; Huang X; Liu H; Wei JY; Zhu L; Qian W
J Exp Clin Cancer Res; 2018 Aug; 37(1):190. PubMed ID: 30103789
[TBL] [Abstract][Full Text] [Related]
19. Exosomes and cancer: from molecular mechanisms to clinical applications.
Jafari A; Babajani A; Abdollahpour-Alitappeh M; Ahmadi N; Rezaei-Tavirani M
Med Oncol; 2021 Mar; 38(4):45. PubMed ID: 33743101
[TBL] [Abstract][Full Text] [Related]
20. The role of exosomes in lung cancer metastasis and clinical applications: an updated review.
Yin L; Liu X; Shao X; Feng T; Xu J; Wang Q; Hua S
J Transl Med; 2021 Jul; 19(1):312. PubMed ID: 34281588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
